Cape Verde vs Sierra Leone: Average non-HDL cholesterol levels
Cape Verde
2.8
in 2018
Sierra Leone
2.8
in 2018
Cape Verde rank
163rd
Sierra Leone rank
163rd
Average non-HDL cholesterol levels over time
- Cape Verde
- Sierra Leone
How they compare
Cape Verde currently reports 2.8 against 2.8 in Sierra Leone, a difference of 0.
The two have swapped places 4 times across 39 shared years of data; in 1980 it was Sierra Leone ahead.
Cape Verde ranks 163rd and Sierra Leone ranks 163rd of 191 countries.
Across the 4 decades both report, Cape Verde averaged higher in 2 and Sierra Leone in 1.
Head to head by decade
| Decade | Cape Verde | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.46 | 2.55 | 0.09 | Sierra Leone |
| 1990s | 2.67 | 2.6 | 0.07 | Cape Verde |
| 2000s | 2.76 | 2.69 | 0.07 | Cape Verde |
| 2010s | 2.8 | 2.8 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Cape Verde or Sierra Leone?
- Cape Verde, at 2.8 against 2.8 in Sierra Leone as of 2018.
- What is the difference in average non-hdl cholesterol levels between Cape Verde and Sierra Leone?
- 0, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Sierra Leone?
- 39 years are reported by both, from 1980 to 2018.
- How do Cape Verde and Sierra Leone rank globally for average non-hdl cholesterol levels?
- Cape Verde ranks 163rd and Sierra Leone ranks 163rd of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.